Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Deferred Isoniazid in HIV-Infected Pregnant Women
NCT01494038Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 4 trial of isoniazid in Tuberculosis (TB), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2014; status: completed.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01494038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494038.